-
Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies
•
Novocure (NASDAQ: NVCR), a Swiss firm renowned for its pioneering Tumor Treating Fields (TTFields) cancer therapy, has received marketing approval from the US Food and Drug Administration (FDA) for its Optune Lua device. This portable device is now cleared for use in combination with PD-1/PD-L1 inhibitors or docetaxel to treat…
-
Novocure Restructures and Prioritizes Pipeline Amid Anticipated NSCLC Approval
•
Novocure (NASDAQ: NVCR), a Switzerland-based developer of Tumor Treating Fields (TTFields) cancer therapeutic technology that uses electric fields to target and eliminate cancer cells, is undergoing a strategic restructuring and portfolio prioritization. The company plans to release 200 staff members, representing approximately a 13% reduction in its workforce, with the…
-
Novocure’s TTFields Misses Overall Survival Endpoint in Ovarian Cancer Phase III Trial
•
Switzerland-based Novocure (NASDAQ: NVCR) has experienced a setback with its Tumor Treating Fields (TTFields) product, as the technology did not meet the overall survival (OS) endpoint in a Phase III trial for ovarian cancer. The ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial was designed to assess the efficacy of TTFields…
-
Zai Lab and Novocure’s TTFields Show Survival Benefit in NSCLC, Despite Stock Plunge
•
China-based Zai Lab Ltd (ZLAB) (NASDAQ: ZLAB; HKG: 9688) and its partner Novocure Ltd (NASDAQ: NVCR) have presented positive results from the Phase III LUNAR clinical trial at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. The trial evaluated the use of Tumor Treating Fields (TTFields) therapy in…
-
Zai Lab and Novocure’s TTFields Device Shows Survival Benefit in Lung Cancer Study
•
Shares in Chinese firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) and its partner Novocure (NASDAQ: NVCR) surged yesterday after the companies revealed positive results from the Phase III LUNAR study. The study assessed the efficacy of the TTFields electrical field medical device in combination with immunotherapy for patients with…
